ChartRow logo
PLSE
$50.84+6.92%
as of close, Oct 20, 2026
☾ AH $50.84 +6.92%
PeersMRNALLYMDTUNHJNJTMO
Share this page

PLSE financial statements

The full income statement, balance sheet, and cash-flow statement for Pulse Biosciences Inc Common Stock (DE) (PLSE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 61.3M2024-09 61.5M2024-12 67.3M2025-03 67.3M2025-06 67.3M2025-09 67.8M2025-12 68.0M2026-03 68.2M2026-06 71.3M+16.4% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue350K0.000.00-100.0%700K-50.6%1.42M
Cost of revenue539K0.000.00-100.0%11.9M+506.9%1.97M
Research & development44.7M+38.3%32.3M+16.3%27.8M+33.4%20.8M-27.2%28.6M+8.3%
Selling, general & administrative32.0M+33.9%23.9M+51.6%15.8M+13.1%14.0M-26.8%19.1M+17.3%
General & administrative—23.9M+51.6%15.8M+13.1%14.0M-26.8%19.1M+17.3%
Amortization of intangibles665K-0.2%666K+0.2%665K+0.0%665K-0.2%666K+0.2%
Operating income-76.9M-36.8%-56.3M-29.1%-43.6M+24.9%-58.1M+7.9%-63.0M-26.1%
Other non-operating income-52.0K-101.9%2.67M+95.9%1.36M+404.5%-448K+30.7%-646K-666.7%
Pre-tax income72.8M+35.8%53.6M+227.0%-42.2M+27.9%-58.5M+8.1%-63.7M-27.7%
Income tax0.000.000.000.000.00
Net income-72.8M-35.8%-53.6M-26.9%-42.2M+27.9%-58.5M+8.1%-63.7M-27.7%
EPS (basic)-$1.08-17.4%-$0.92-8.2%-$0.85+50.6%-$1.72+24.6%-$2.28-6.5%
Weighted-avg shares (basic)67.4M+15.4%58.4M+17.4%49.7M+46.6%33.9M+21.4%28.0M+20.3%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
83.4M-30.2%119M+163.5%45.3M-27.1%62.1M+37.1%45.3M+102.9%
Cash & equivalents80.7M-31.6%118M+166.1%44.4M-27.4%61.1M+37.8%44.4M+256.0%
Cash & short-term investments
————28.6M
Accounts receivable274K0.00—0.00-100.0%61.0K
Inventory136K0.00—0.00-100.0%5.82M
Prepaid expenses2.28M+61.3%1.41M+46.5%963K-4.5%1.01M+4.7%963K-48.3%
94.5M-28.6%132M+123.9%59.2M-24.0%77.9M+31.7%59.2M+43.3%
Property, plant & equipment1.05M-9.4%1.16M-24.1%1.53M-22.1%1.96M-20.3%2.46M-0.6%
Operating lease right-of-use6.01M-16.1%7.16M-1.3%7.26M-10.0%8.06M-8.2%8.79M-6.9%
Goodwill2.79M+0.0%2.79M+0.0%2.79M+0.0%2.79M+0.0%2.79M+0.0%
Intangible assets575K-52.9%1.22M-35.3%1.89M-26.1%2.55M-20.7%3.22M-17.2%
Other non-current assets691K+2.1%677K+85.5%365K+0.0%365K+0.0%365K+0.0%
7.92M-21.2%10.1M+49.9%6.71M+12.2%5.98M-10.8%6.71M-11.6%
Accounts payable2.78M+66.0%1.67M-8.9%1.84M+16.7%1.57M-14.3%1.84M+6.9%
Accrued liabilities3.58M-49.1%7.03M+84.2%3.81M+47.0%2.60M-40.9%4.39M-17.6%
Deferred revenue———0.00-100.0%16.0K
Current lease liability1.57M+15.9%1.35M+28.1%1.06M+18.1%896K+15.8%774K+42.8%
13.9M-21.1%17.6M+19.0%14.8M-81.5%80.1M+441.6%14.8M-19.6%
Non-current lease liability5.96M-21.0%7.54M-6.7%8.09M-11.6%9.14M-8.9%10.0M-7.2%
Operating lease liability (total)7.53M-15.4%8.90M-2.7%9.14M-8.9%10.0M-7.2%10.8M-4.8%
80.7M-29.8%115M+158.9%44.4M+2073.3%-2.25M-106.3%35.7M+55.9%
Preferred stock0.000.000.000.000.00
Common stock68.0K+3.0%66.0K+20.0%55.0K+48.6%37.0K-32.7%55.0K+120.0%
Additional paid-in capital544M+7.6%505M+32.5%381M+30.4%292M-23.3%381M+95.1%
Retained earnings-463M-18.6%-391M-15.9%-337M-14.3%-295M+12.5%-337M-95.3%
Accumulated other comprehensive income—0.000.000.000.00+100.0%
Total liabilities & equity94.5M-28.6%132M+123.9%59.2M-24.0%77.9M+31.7%59.2M+43.3%
Common shares issued67.8M+2.9%65.9M+19.6%55.1M+48.1%37.2M-32.5%55.1M+115.8%
Common shares outstanding67.8M+2.9%65.9M+19.6%55.1M+48.1%37.2M-32.5%55.1M+115.8%
Shares outstanding (cover)68.0M+1.1%67.3M+21.8%55.2M+46.9%37.6M+26.1%29.8M+14.2%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-54.1M-48.9%-36.3M-10.0%-33.0M+29.7%-47.0M+13.1%-54.1M-53.0%
Depreciation & amortization1.07M-9.1%1.18M-2.4%1.21M-10.9%1.35M+18.2%1.15M+4.7%
Intangible amortization665K-0.2%666K+0.2%665K+0.0%665K-0.2%666K+0.2%
Share-based compensation21.5M+57.9%13.6M+89.2%7.18M+38.3%5.19M-64.4%14.6M+44.9%
Deferred income taxes——0.000.000.00
Change in receivables274K0.000.00+100.0%-61.0K-200.0%61.0K
Change in inventory136K0.000.00-100.0%2.65M-54.4%5.82M
Change in payables1.13M+663.2%-201K-176.4%263K+120.2%-1.30M-212.4%1.16M+536.1%
-335K-168.0%-125K-3.3%-121K+69.8%-401K-105.3%7.56M-24.7%
Capital expenditure315K+152.0%125K+3.3%121K-69.8%401K-8.2%437K-0.9%
Free cash flow-54.4M-49.3%-36.5M-10.0%-33.2M+30.1%-47.4M+13.1%-54.5M-52.3%
Acquisitions0.000.000.000.000.00
Sales/maturities of investments———0.00-100.0%8.00M-77.1%
17.2M-84.4%110M+572.1%16.4M-79.5%79.9M+27.5%62.7M+103.0%
Long-term debt issued0.000.000.000.00-100.0%1.94M
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.00-100.0%14.9M-73.8%56.7M+92.6%
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Net change in cash-37.3M-150.6%73.7M+539.2%-16.8M-151.6%32.5M+101.4%16.2M+190.3%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap933M-20.3%1.17B+74.0%673M+552.7%103M-76.6%441M-29.1%
P/S2667.1×——66.4×-78.7%311.3×
P/B11.6×+13.5%10.2×-21.0%12.9×-22.5%16.7×+34.7%12.4×-54.5%
Source filing10-K10-K10-K10-K10-K

About this data

Source: PLSE’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PLSE filings on SEC EDGAR → Not investment advice.